Nusafe Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Medical Equipment and Supplies Manufacturing | Other Miscellaneous Store Retailers | Rental and Leasing Services | Engineering Services | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | All Other Support Services | Outpatient Care Centers

Full name: Nusafe Sp. z o.o.

Profile Updated: April 15, 2025

Nusafe Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was incorporated on May 25, 2016. A growth of 7.18% was recorded in its total assets.

Headquarters
Ul. Poleczki 35
Warsaw; Mazowieckie; Postal Code: 02-822

Contact Details: Purchase the Nusafe Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Nusafe Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Nusafe Sp. z o.o. report to view the information.

Incorporation Date:

May 25, 2016

Key Executives

Purchase this report to view the information.

Management Board Member

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Nusafe Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating Profit/Loss (EBIT)

-8.28%▼

EBITDA

-14.76%▼

Net Profit/Loss for the Period

-7.93%▼

Total Assets

7.18%▲

Total Equity

-28.7%▼

Return on Equity (ROE)

-13.67%▼